ImmunologybioRxiv
Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice
F. H. Damron, K. S. Lee, N. A. Rader…·R. K. Ernst
This study shows an intranasal VLP-RBD vaccine with BECC470 adjuvant provides protection against Delta SARS-CoV-2 in mice, with mucosal immunity and reduced lung inflammation.
DOI 10.1016/j.vaccine.2023.06.080